Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET.
Front Oncol
; 12: 1026608, 2022.
Article
en En
| MEDLINE
| ID: mdl-36620558
Texto completo:
1
Bases de datos:
MEDLINE
Idioma:
En
Revista:
Front Oncol
Año:
2022
Tipo del documento:
Article